Email ID : 
Password : 
Forgot Your Password ? 

Only Report Titles
Titles & Keywords
NOTE: Site best viewed with Internet Explorer
  IMMUNOASSAY SYSTEMS
A Global Strategic Business Report

This report analyzes the worldwide markets for Immunoassay Systems in US$ Million by the following product segments (includes Immunoassay Analyzers and Reagents) - Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems. The report provides separate comprehensive analytics for the US, Canada, Japan Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. A six-year historic analysis is also provided for these markets. The report profiles 69 companies including many key and niche players such as Abbott Laboratories, Beckman Coulter Inc., bioMérieux, Bio-Rad Laboratories Inc., Ortho-Clinical Diagnostics Inc., Roche Diagnostics, and Siemens Healthcare Diagnostics. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

CODE:    MCP-3522  PAGES:    589
PRICE:    $4500  DATE:       August 2010
COMPANIES:  69  MARKET DATA TABLES:   203
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

 TABLE OF CONTENTS  
  IMMUNOASSAY SYSTEMS (Complete Report) Pages : 589   | $4500
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS5$100
   Study Reliability and Reporting Limitations.....I-1  
   Disclaimers.....I-2  
   Data Interpretation & Reporting Level.....I-3
Quantitative Techniques & Analytics.....I-3
Product Definitions and Scope of Study.....I-3
  
   Enzyme Immunoassay.....I-4
Fluorescence Immunoassay.....I-4
Chemiluminescence Immunoassay.....I-4
  
   Radioimmunoassay.....I-5
Nephelometric Immunoassay.....I-5
  
II. EXECUTIVE SUMMARY81$2350
  1. INDUSTRY OVERVIEW.....II-19 $1850  
   In-Vitro Diagnostics – A Rudimentary Overview.....II-1
Technologies Used in IVD.....II-1
1$100
   Market Structure.....II-21$100
   Factors Influencing IVD Industry: On a Scale of 1-5.....II-3
Key Statistical Findings:.....II-3
Table 1: World In-Vitro Diagnostic Products Market by End-Use Segment (2009) - Percentage Breakdown by Value Sales for Hospital Labs, Commercial Labs, Self-Testing and POC (includes corresponding Graph/Chart).....II-3

Table 2: Global IVD Market (2008): Percentage Share Breakdown of Value Sales by Country/Region (includes corresponding Graph/Chart).....II-3
1$350
   Table 3: Global IVD Market (2008): Percentage Share Breakdown of Revenue by Product Segment (includes corresponding Graph/Chart).....II-4
Competition in the IVD Market.....II-4
Table 4: Global IVD Market (2009): Percentage Share Breakdown of Value Sales by Leading Players (includes corresponding Graph/Chart).....II-4
1$350
   Immunoassays – A Key Component in the IVD Market.....II-5
Waxing Importance of Immunoassays in the Overall Diagnostic Test Market.....II-5
1$100
   Expanding Immunoassay Applications Boost Demand for Immunoassay Systems.....II-6 1$100
   Table 5: Global Laboratory Based Immunoassay Market (2009): Percentage Share Breakdown of Value Sales by Analyte Type (includes corresponding Graph/Chart).....II-7

Table 6: Recent Past Perspective of the World Immunoassay Market by End-Use Industry (2006): Percentage Breakdown by Value Sales for Clinical, Food and Environment Industries (includes corresponding Graph/Chart).....II-7
Increasing Use of Immunoassays in Food Sciences and Quality Control.....II-7
1$350
   Immunoassay Techniques for Testing Environmental Samples Makes a Mark.....II-8
Application of Immunoassays for Trace Methodology.....II-8
Technology Innovation – The Name of the Game.....II-8
1$350
   Table 7: Worldwide Immunoassay Systems Market (2007) - Percentage Share Breakdown of Value Sales by Leading Players (includes corresponding Graph/Chart).....II-9
1$350
  2. INDUSTRY TRENDS & ISSUES.....II-103 $300  
   Shift Towards Point-of-Care Test Systems.....II-10
Hospital and Laboratory Consolidations Drive the Market for Immunoassay
  Products.....II-10
Advancement in Genetic Research Drives the Growth.....II-10
1$100
   Introduction of Portable Immunoassay Systems Energizes the Market.....II-11
Increasing Demand for Random Access Immunoanalyzers..........II-11
Task-Targeted Automated Chemiluminescent Assays to Penetrate.....II-11
Instrument Rental - Name of the New Game........II-11
Changing Scene for Immunodiagnostic Testing........II-11
1$100
   Laboratory Automation on Rise.....II-12
Market for Adjunctive Therapies to Grow Fast.....II-12
1$100
  3. CONCEPTUAL OVERVIEW.....II-1330 $2050  
   Immunoassays - Definition and Description.........II-13
Turning the Hour Glass Back.....II-13
Immunoassay Analyzers.....II-13
1$100
   Immunoassay Reagents.....II-14
Radioimmunoassay.....II-14
Non-Isotopic Immunoassays.....II-14
1$100
   Customized Immunoassays.....II-15
Demerits of Immunoassays.....II-15
Labels - Necessary for Detection.....II-15
1$100
   Select End-Use Applications of Immunoassays.....II-16
Infectious Disease.....II-16
Endocrine Testing Procedures.....II-16
Blood Processing Market.....II-16
1$100
   Cancer Testing Markets.....II-17
Drugs of Abuse Testing Market.....II-17
1$100
   Therapeutic Drug Monitoring.....II-18
Immune Disease.....II-18
Blood Grouping and Typing.....II-18
Components of Immunoassays.....II-18
1$100
   Signal Response.....II-19
Labeled Tracer.....II-19
Binder.....II-19
Buffer Matrix.....II-19
Incubation Conditions.....II-19
Separation Process.....II-19
1$100
   Standard Specimens.....II-20
Control Specimens.....II-20
Unknown Specimens.....II-20
Chemiluminescent Substrates - Growing Appeal.....II-20
Radioimmunoassay Analyzers, Gamma Counters.....II-20
1$100
   Fundamentals of Operation.....II-211$100
   Problems Involved.....II-221$100
   Enzyme Immunoassay Analyzers, Fluorescence Immunoassay Analyzers and
  Chemiluminescence’s Immunoassay Analyzers.....II-23
1$100
   Enzyme Immunoassays.....II-24
Automation Enabled.....II-24
Customization of Assays.....II-24
1$100
   ELISA - A Flexible Enzyme Immunoassay Test..........II-25
Constituents of ELISA.....II-25
Working.....II-25
Binding the Antigen and Antibody.....II-25
1$100
   Conjugate Binding.....II-26
Evidence of Binding.....II-26
Fluorescence Immunoassay - Operating Principle.....II-26
Light Sources.....II-26
Sample Cell.....II-26
1$100
   Filters.....II-27
Detector.....II-27
Time-Resolved Fluoroimmunoassay.....II-27
Chemiluminescence Immunoassay.....II-27
1$100
   Types of Immunoassay Techniques.....II-28
Fluorescence Polarization Immunoassay.....II-28
Radiative Energy Attenuation (REA).....II-28
1$100
   Substrate-Labeled Fluorescence.....II-29
Enzyme Immunoassay with Fluorescence Detection.....II-29
Solid-Phase Microsphere Immunoassay.....II-29
1$100
   Microparticle Enzyme Immunoassay (MEIA).....II-30
Enzyme-Linked Fluorescence Immunoassay.....II-30
ELISA With Photometric Detection.....II-30
1$100
   Dry-Phase Techniques.....II-31
Sandwich Technique.....II-31
Competitive Binding.....II-31
Reversible Complex Formation.....II-31
The Phase of Development.....II-31
1$100
   Problems and Limitations.........II-321$100
   Purchase Considerations..........II-33
Cost Considerations.........II-33
Nephelometric Immunoassay.....II-33
1$100
   Nephelometry.....II-34
Types of Scatter...........II-34
Rayleigh Scatter.....II-34
Mie Scatter.....II-34
Rayleigh-Debye Scatter.....II-34
Key Components of Nephelometric Immunoassay Analyzers.........II-34
1$100
   Light Sources.....II-35
Detectors.....II-35
Automated Nephelometers.........II-35
1$100
   Modes of Operation.........II-36
Nephelometric Immunoassay Procedures.........II-36
1$100
   Associated Problems...........II-37
Purchase Considerations.........II-37
1$100
   Test Menu.....II-38
Analytical Range.....II-38
Linearity.....II-38
Specificity.....II-38
Precision.....II-38
Stability.....II-38
Carryover.....II-38
1$100
   Downtime.....II-39
Upgrading / Interfacing.....II-39
Reagents.....II-39
Additional Features..........II-39
Competing Technologies.....II-39
Mature Technologies..........II-39
Cell Counting.....II-39
1$100
   Clinical Chemistry.....II-40
Microbiology.....II-40
Emerging Technologies...........II-40
DNA Probes.....II-40
Miniaturization and Microchip Fabrication.....II-40
1$100
   Blood Glucose Testing.....II-41
Immunohistochemistry (IHC).....II-41
Non-Invasive Technology.....II-41
Image Analysis and Pattern Recognition.....II-41
1$100
   Rapidly Growing Molecular Diagnostics.....II-42
New Technologies.....II-42
High-Definition Cell Assay Technologies:.....II-42
(1) Rapid, High-Definition Assays for Cellular Efficacy (RHACE).....II-42
(2) Single-Cell Analysis of Physiological Effects (SAPhE).....II-42
(3) Matrix Analysis of Genomically-Indexed Cells (MAGIC).....II-42
1$100
  4. PRODUCT LAUNCHES.....II-439 $700  
   Roche Introduces Roche Cardiac 200.....II-43
Bio-Rad Introduces Bio-Plex Pro™.....II-43
IDS Introduces IDS-iSYS hGH.....II-43
IDS Introduces IDS-iSYS PINP.....II-43
IDS Introduces IDS-iSYS & IDS-iSYS Vitamin D Assay.....II-43
1$100
   Abbott Introduces ARCHITECT c4000 Clinical Chemistry Analyzer.....II-44
Siemens Introduces Clinical Laboratory Automation Solutions.....II-44
1$100
   Ortho-Clinical Diagnostics Introduces New Laboratory System.....II-451$100
   Cell Biosciences Launches Kit for Analysis of Oncoproteins.....II-46
Roche Diagnostics Introduces Pre-Eclampsia In-Vitro Tests across Europe.....II-46
Abbott To Launch New ARCHITECT® ci4100™ Integrated Immunoassay & Clinical Chemistry
  System.....II-46
1$100
   Abbott Introduces ARCHITECT® i1000SR® Immunochemistry Analyzer.....II-47
Ortho Clinical Diagnostics Unveils Vitros® 3600 Immunodiagnostic System and Vitros®
  5600 Integrated System.....II-47
1$100
   PerkinElmer Releases New AplhaLISA™ Immunoassay Diagnostic Kits.....II-481$100
   Assay Designs Introduces ImmunoSet™ ELISA Development Kit.....II-49
Trinity Biotech Introduces New Lyme Enzyme Diagnostic Products for European Markets
  (Europe).....II-49
bioMérieux Introduces VIDAS® NT-proBNP.....II-49
1$100
   Beckman Coulter Introduces UniCel DxC 880i Synchron® Access®.....II-50
Beckman Coulter Introduces UniCel® DxI 600.....II-50
bioMérieux Introduces VIDAS® B•R•A•H•M•S PCT® Assay .....II-50
Siemens Rolls Out ADVIA Centaur® Cyclosporine (CsA) Assay.....II-50
Ortho-Clinical Diagnostics Launches VITROS Troponin I ES Assay.....II-50
1$100
   Ortho-Clinical Diagnostics Introduces VITROS® Rubella IgG Assay.....II-51
1$100
  5. RECENT INDUSTRY ACTIVITY.....II-528 $600  
   bioMerieux Acquires Meikang Biotech.....II-52
Bio-Rad Purchases Biotest AG’s Diagnostics Businesses.....II-52
Immunodiagnostic Systems Receives FDA Approval for IDS-iSYS Immunoassay
  Analyzer.....II-52
Roche Diagnostics Receives Immunoassay Contract from Premier Purchasing Partner
  .....II-52
1$100
   Ortho Clinical Gets US FDA Approval for Usage of VITROS® Hepatitis B Surface Antigen
  (HBsAG) on VITROS® 5600 Integrated & VITROS® 3600.....II-53
Neogen Takes Over International Diagnostic Systems.....II-53
eBioscience Acquires Bender MedSystems.....II-53
1$100
   Inverness to Acquire ACON’s Lateral Flow Immunoassay Diagnostics Business.....II-54
Beckman Coulter to Purchase Olympus Corp’s Diagnostics Division.....II-54
Instrumentation Laboratory Secures FDA Approval for ACL AcuStarTM Hemostasis Testing
  System.....II-54
1$100
   Abbott Receives FDA Premarket Approval for ARCHITECT CORE.....II-55
Ivax Diagnostics Inks Distribution Deal with Lin-Zhi International.....II-55
Axis-Shield Inks Distribution Deals for Marketing Afinion.....II-55
bioMerieux and Shanghai Kehua Set Up JV.....II-55
1$100
   bioMerieux and Quidel to Form Global Alliance for Rapid Diagnostics.....II-56
Johnson & Johnson Nordic AB Takes Over Amic.....II-56
1$100
   Roche Acquires Ventana Medical Systems, Inc......II-57
Abbott Terminates Sale Agreement with GE.....II-57
Abbott Inks Agreement with Premier, Inc......II-57
Beckman Coulter Renews Agreement with MedAssets.....II-57
Beckman Coulter Extends Agreement Amerinet.....II-57
1$100
   Beckman Coulter Extends Partnership with Bio-Rad.....II-58
Siemens Acquires Dade Behring.....II-58
Roche Acquires BioVeris.....II-58
Siemens Healthcare Diagnostics Inks Agreement with Amerinet.....II-58
Siemens Healthcare Diagnostics Signs Agreement with Bio-Rad.....II-58
1$100
   Siemens Medical Solutions USA Sets Up Siemens Healthcare Diagnostics.....II-59
1$100
  6. FOCUS ON SELECT MARKET PARTICIPANTS.....II-604 $400  
   Abbott Laboratories (US).....II-60
Beckman Coulter Inc. (US).....II-60
1$100
   bioMérieux (France).....II-61
Bio-Rad Laboratories Inc. (US).....II-61
1$100
   Ortho-Clinical Diagnostics Inc (US).....II-62
Roche Diagnostics (US).....II-62
1$100
   Siemens Healthcare Diagnostics (US).....II-63
1$100
  7. GLOBAL MARKET PERSPECTIVE.....II-64   
   Table 8: World Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-641$350
   Table 9: World Historic Review for Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-651$350
   Table 10: World 11-Year Perspective for Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).....II-661$350
   Immunoassay Systems Market by Product Segment.....II-67
Table 11: World Recent Past, Current & Future Analysis for Enzyme Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-67
1$350
   Table 12: World Historic Review for Enzyme Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-681$350
   Table 13: World 11-Year Perspective for Enzyme Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).....II-691$350
   Table 14: World Recent Past, Current & Future Analysis for Fluorescence Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-701$350
   Table 15: World Historic Review for Fluorescence Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-711$350
   Table 16: World 11-Year Perspective for Fluorescence Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).....II-721$350
   Table 17: World Recent Past, Current & Future Analysis for Chemiluminescence Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe,Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-731$350
   Table 18: World Historic Review for Chemiluminescence Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-741$350
   Table 19: World 11-Year Perspective for Chemiluminescence Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).....II-751$350
   Table 20: World Recent Past, Current & Future Analysis for Radio Immunoassay Systems & Reagents by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-761$350
   Table 21: World Historic Review for Radio Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-771$350
   Table 22: World 11-Year Perspective for Radio Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).....II-781$350
   Table 23: World Recent Past, Current & Future Analysis for Nephelometric Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....II-791$350
   Table 24: World Historic Review for Nephelometric Immunoassay Systems by Geographic Region – US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....II-801$350
   Table 25: World 11-Year Perspective for Nephelometric Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific and Latin American Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).....II-811$350
III. MARKET71$2150
  1. THE UNITED STATES.....III-120 $1775  
   A. Market Analysis.....III-1
Market Overview.....III-1
Trends in the Marketplace.....III-1
Leading Players.....III-1
US In-Vitro Diagnostics Market – A Special Review.....III-1
1$75
   Evolving Trends to Benefit IVD Market.....III-21$75
   Key Statistics.....III-3
Table 26: US In-Vitro Diagnostics (IVD) Market (2008): Percentage Share Breakdown of Dollar Sales by Segment (includes corresponding Graph/Chart).....III-3

Table 27: US In-Vitro Diagnostics (IVD) Market (2009): Percentage Share Breakdown of Revenue by Leading Players (includes corresponding Graph/Chart).....III-3
US Market for Clinical Laboratory Instruments.....III-3
Laboratory Consolidation and Automation on a Rise.....III-3
1$200
   Product Launches.....III-46$450
   Strategic Corporate Developments.....III-105$375
   Focus on Select Players.....III-15
Abbott Laboratories.....III-15
Beckman Coulter.....III-15
1$75
   Bio-Rad Laboratories Inc......III-16
Ortho-Clinical Diagnostics Inc.....III-16
1$75
   Roche Diagnostics.....III-17
Siemens Healthcare Diagnostics.....III-17
1$75
   B. Market Analytics.....III-18
Table 28: US Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-18
1$200
   Table 29: US Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-191$200
   Table 30: US 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-20
1$200
  2. CANADA.....III-213 $500  
   Market Analysis.....III-21
Table 31: Canadian Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-21
1$200
   Table 32: Canadian Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-221$200
   Table 33: Canadian 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-23
1$200
  3. JAPAN.....III-244 $600  
   A. Market Analysis.....III-24
Market Highlights........III-24
Strategic Corporate Development.....III-24
Focus on Key Players.....III-24
Fujirebio Inc.....III-24
1$75
   Tosoh Corporation.....III-25
B. Market Analytics.....III-25
Table 34: Japanese Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-25
1$200
   Table 35: Japanese Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-261$200
   Table 36: Japanese 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-27
1$200
  4. EUROPE.....III-2811 $1225  
   A. Market Analytics.....III-28
Current & Future Analysis.....III-28
Overview of Immunochemistry Analyzer Market in Europe.III-28
High Switching Costs and Restricted Hospital Budgets Inhibit Market Expansion.....III-28
1$75
   Panorama of the European Immunoassay Market.....III-29
Challenges.....III-29
Decreasing Profitability.....III-29
1$75
   Immunodiagnostic Products Market – A Focus.....III-30
Trends in Immunodiagnostic Market..........III-30
1$75
   IVD Market - Recent Past Perspective.....III-31
Table 37: European IVD Market, 2006: Leading Players by Market Share for Roche, Dade, Abbott, Beckman, Bayer, bioMerieux, OCD and Others (includes corresponding Graph/Chart).....III-31
Product Launches.....III-31
1$200
   Strategic Corporate Development.....III-321$75
   B. Market Analytics.....III-33
Table 38: European Recent Past, Current & Future Analysis for Immunoassay Systems by Geographic Region – France, Germany, Italy, the UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-33
1$200
   Table 39: European Historic Review for Immunoassay Systems by Geographic Region – France, Germany, Italy, the UK and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-341$200
   Table 40: European Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-351$200
   Table 41: European Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-361$200
   Table 42: European 11-Year Perspective for Immunoassay Systems by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, the UK and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-371$200
   Table 43: European 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-38
1$200
  4a. FRANCE.....III-394 $600  
   A. Market Analysis.....III-39
Current & Future Analysis.....III-39
Strategic Corporate Development.....III-39
bioMérieux – A Key Player.....III-39
1$75
   B. Market Analytics.....III-40
Table 44: French Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-40
1$200
   Table 45: French Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-411$200
   Table 46: French 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-42
1$200
  4b. GERMANY.....III-434 $600  
   A. Market Analysis.....III-43
Current & Future Analysis.....III-43
In-Vitro Diagnostics Market – A Snapshot.....III-43
1$75
   B. Market Analytics.....III-44
Table 47: German Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-44
1$200
   Table 48: German Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-451$200
   Table 49: German 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-46
1$200
  4c. ITALY.....III-473 $500  
   Market Analysis.....III-47
Table 50: Italian Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-47
1$200
   Table 51: Italian Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-481$200
   Table 52: Italian 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-49
1$200
  4d. THE UNITED KINGDOM.....III-504 $600  
   A. Market Analysis.....III-50
Current & Future Analysis.....III-50
IDS – A Key Player in the UK.....III-50
Product Launches.....III-50
1$75
   B. Market Analytics.....III-51
Table 53: UK Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-51
1$200
   Table 54: UK Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-521$200
   Table 55: UK 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-53
1$200
  4e. REST OF EUROPE.....III-544 $600  
   A. Market Analysis.....III-54
Current and Future Analysis.....III-54
Strategic Corporate Development.....III-54
1$75
   B. Market Analytics.....III-55
Table 56: Rest of Europe Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-55
1$200
   Table 57: Rest of Europe Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-561$200
   Table 58: Rest of Europe 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-57
1$200
  5. ASIA-PACIFIC.....III-5811 $1025  
   A. Market Analysis.....III-58
Market Highlights..........III-58
Growing In-Vitro Diagnostics (IVD) Market Fuels the Demand for Immunoassay
  Instruments in Asia.....III-58
Review of Select Asian Markets.....III-58
China.....III-58
Chinese Market for Diagnostic Products.........III-58
1$75
   Influencing Forces.....III-59
Market Characteristics.....III-59
Competitive Analysis.....III-59
1$75
   Strategies.....III-60
End-User Analysis.....III-60
Hospitals.....III-60
Laboratories.....III-60
1$75
   General Population.....III-61
Difficulties Posed by the Market.....III-61
Distribution Channels.....III-61
India.....III-61
Emerging Trends in the Indian Immunodiagnostics Market.....III-61
1$75
   Key Statistics.....III-62
Table 59: Indian Immunochemistry Instruments & Reagents Market (2009): Percentage Share Breakdown of Revenue by Segment.....III-62

Table 60: Indian Immunochemistry Instruments & Reagents Market (2009): Percentage Share Breakdown of Revenue by Product Segment (includes corresponding Graph/Chart).....III-62
1$200
   Table 61: Indian Immunoassay Reagent Market (2009): Percentage Share Breakdown of Revenue by Reagent Type (includes corresponding Graph/Chart).....III-63
Malaysia.....III-63
Health Care Services.........III-63
1$200
   Singapore.....III-64
Clinical Laboratory Equipment Market in Singapore.........III-64
Market Characteristics.....III-64
Imports Scene.....III-64
1$75
   Distribution.....III-65
End-User Analysis.....III-65
Strategic Corporate Developments.....III-65
1$75
   B. Market Analytics.....III-66
Table 62: Asia Pacific Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-66
1$200
   Table 63: Asia Pacific Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-671$200
   Table 64: Asia Pacific 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-68
1$200
  6. LATIN AMERICA.....III-693 $500  
   Market Analysis.....III-69
Table 65: Latin American Recent Past, Current & Future Analysis for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).....III-69
1$200
   Table 66: Latin America Historic Review for Immunoassay Systems by Product Segment – Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2001 through 2006 (includes corresponding Graph/Chart).....III-701$200
   Table 67: Latin American 11-Year Perspective for Immunoassay Systems by Product Segment – Percentage Breakdown of Value Sales for Enzyme Immunoassay Systems, Fluorescence Immunoassay Systems, Chemiluminescence Immunoassay Systems, Radio Immunoassay Systems, and Nephelometric Immunoassay Systems Markets for 2005, 2010 & 2015 (includes corresponding Graph/Chart).....III-711$200
IV. COMPETITIVE LANDSCAPE 418$995
  
Total Companies Profiled: 69 (including Divisions/Subsidiaries - 108)

Region/Country                 Players


The United States                 48   
Canada                             8
Japan                             11
Europe                            33
     France                        4
     Germany                       9
     The United Kingdom            3
     Italy                         4
     Rest of Europe               13
Asia-Pacific (Excluding Japan)     7
Middle East                        1
Click here to request a full table of contents and more details on this project.		  
 
 
Due to the proprietary nature, our previews are offered only to manufacturers, top-tier management consultants, investment banks, and investment research groups.

© Copyrights 2010, Global Industry Analysts, Inc., USA.